Like PD-1, CTLA4 is an inhibitory receptor that prevents CD28-mediated co-stimulatory signals for immune response [6], while LAG3 contributes to a state of T cell dysfunction in the tumor microenvironment [8]. The gene discussed is CTLA4; the disease is neoplasm.